Evan See

Evan See

JOURNALIST

Laboratoires Pierre Fabre CEO Eric Ducournau says it is focusing on developing its R&D portfolio in pharmaceuticals, while expanding its presence in Asia.

An ‘Asia-first’ strategy for cosmetics and pharma maker Pierre Fabre; seeks to double regional revenue

2026-11-09T04:00:00.000Z
Acting Minister for Manpower Jasmin Lau says that Singapore, as Asean chair in 2027, aims to address regional concerns over AI use.

No Asean country has figured out how to manage AI’s impact on jobs: Jasmin Lau

2026-11-05T10:03:12.000Z
Some hawker centres and markets have experienced a drop in footfall, though the extent of this decline varies across centres.

Singapore’s food supply unaffected by haze; no additional financial support planned for hawkers: Grace Fu

2026-11-03T06:40:02.000Z
Fu says Singapore had offered civilian assistance to support Indonesian firefighters, as well as operational support for cloud-seeding.

Singapore to ratify Asean haze coordination centre agreement ‘in the next few days’: Grace Fu

2026-11-03T05:18:53.000Z
NeoSci Ventures’ co-founders Dr Timothy Lu and Daphne Teo say they have been investing in the biotech space for 15 years.

Venture builder NeoSci Ventures raises S$70 million for inaugural biotech fund

2026-11-03T01:00:00.000Z
iX Biopharma’s Wafermine is a non-opioid sublingual ketamine wafer used for treating acute moderate to severe pain.

iX Biopharma: Wafermine plans ‘not dependent’ on Nevada partner Orion, which lacks state licence

2026-11-02T09:06:27.000Z
Senior Minister of State Tan Kiat How says Google’s initiative with NHG Health will help to move care beyond hospitals into communities and homes.

Google to expand AI partnerships with public healthcare groups, establish new Singapore research hub

2026-10-29T07:27:26.000Z
Kabam Robotics co-founders Kelvin Wee (left) and Benjamin Chia with the company’s robots in 2023.

Singapore security robotics firm Kabam to cease operations on Nov 20

2026-10-22T05:03:19.000Z
From left: BT’s Dylan Tan; Dr Sue-Anne Toh of Novi Health; Prof Roger Foo from Yong Loo Lin School of Medicine; and Yeoh Keat Chuan of Temasek International.

Investing in health: Small habits for a lifetime of returns

2026-10-21T23:00:00.000Z
Roland Ong, founder of Nanyang Biologics, believes the company’s listing rides a wave of investor interest that has returned to the biotech industry, in part due to the rise of AI.

Nasdaq listing awaits Singapore’s US$1.5 billion AI drug-discovery biotech Nanyang Biologics

2026-10-14T07:00:00.000Z